Acute cardiac failure in neuroleptic malignant syndrome

European Journal of Heart Failure

Volumn 5, Issue 4, 2003, Pages 575-578

  Sparrow, Patrick ^a,c   Murnaghan, Dermot ^a   Kearney, Peter ^a   Hogan, John ^a   Sheppard, Mary N ^b  

^a Department of Medicine National University of Ireland Cork   (Ireland)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Acute cardiac failure; Myocyte necrosis; Neuroleptic malignant syndrome; Vacuolation

Indexed keywords

LITHIUM; THIORIDAZINE;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; CELL DEATH; CELL VACUOLE; FEMALE; HEART FAILURE; HEART MUSCLE; HUMAN; HUMAN TISSUE; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL; SKELETAL MUSCLE;

ADULT; FATAL OUTCOME; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MUSCLE CELLS; MUSCLE, SKELETAL; MYOCARDIUM; NECROSIS; NEUROLEPTIC MALIGNANT SYNDROME;

EID: 0041967441     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(03)00036-9     Document Type: Article

References (15)

1. Shalev A, Harmesh H, Munitz H. Mortality from neuroleptic malignant syndrome. J Clin Psychiatry 1989;50:18-25.
2. Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985;142:1137-45.
3. Parada MA, de Parada MP, Rada P, Hernandez L. An animal model for neuroleptic malignant syndrome. Brain Res 1995;674(1):117-21.
4. Fiebel JH, Schiffer RB. Sympathoadrenomedullary hyperactivity in the neuroleptic malignant syndrome. Am J Psych 1981;138:1115-6.
5. Purkhardt C, Kelly JP, Lim JH. Neuroleptics inhibit complex 1 of the electron complex chain. Amt Neurol 1993;33:512-7.
6. Watanabe K, Izumi T, Inomata T, Miyakita Y, Masani F, Shibata A. Clustered droplets in the endomyocardial biopsies from a patient with neuroleptic malignant syndrome. Clin Cardiol 1994;17:623-6.
7. Bennaissa ML, Bekka R, Baud FJ. Acute cardiac failure in a case of rapidly lethal NMS. Int Care Med 1998;24:86-92.
8. Becker D, Birger M, Samuel E, Floru S. Myocardial Infarction: an unusual complication of neuroleptic malignant syndrome. J Nerv Ment Dis 1988;176:377-8.
9. Behan WM, Madigan M, Clark BJ, Goldberg J, Mc Lellan DR. Muscle changes in the neuroleptic malignant syndrome. J Clin Pathol Mar 2000;53(3):223-7.
10. Bertorini TE. Myoglobinaemia, malignant hyperthermia, neuroleptic malignant syndrome and serotonin syndrome. Neurol Clinic 1997;15:649-71.
11. Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SHL. QTc interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 2000;355:1048-52.
12. Kline IK. Myocardial alterations associated with phaeochromocytomas. Am J Path 1961;38:539-51.
13. Van Vliet P, Burchell HB, Titus JL. Focal myocarditis associated with phaeochromocytoma. N Engl J Med 1966;274:1102-8.
14. Sardesai S, Mourant, AJ, Sivathandon Y, Farrow R, Gibbons DO. Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure. Br Heart J 1990;63:234-7.
15. Scarlet JD, Zimmerman R, Berkovic SF. Neuroleptic malignant syndrome. Aust NZ J Med 1983;13:70-3.